254 related articles for article (PubMed ID: 17463165)
1. Zinc inhibits doxorubicin-activated calcineurin signal transduction pathway in H9c2 embryonic rat cardiac cells.
Merten KE; Jiang Y; Kang YJ
Exp Biol Med (Maywood); 2007 May; 232(5):682-9. PubMed ID: 17463165
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
Merten KE; Jiang Y; Feng W; Kang YJ
J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
[TBL] [Abstract][Full Text] [Related]
3. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway.
Yoon JJ; Son CO; Kim HY; Han BH; Lee YJ; Lee HS; Kang DG
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374365
[TBL] [Abstract][Full Text] [Related]
4. Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.
Asadi F; Razmi A; Dehpour AR; Shafiei M
J Pharm Pharmacol; 2016 Apr; 68(4):485-93. PubMed ID: 26945895
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium.
Kalivendi SV; Konorev EA; Cunningham S; Vanamala SK; Kaji EH; Joseph J; Kalyanaraman B
Biochem J; 2005 Jul; 389(Pt 2):527-39. PubMed ID: 15799720
[TBL] [Abstract][Full Text] [Related]
8. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
9. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.
Guo RM; Xu WM; Lin JC; Mo LQ; Hua XX; Chen PX; Wu K; Zheng DD; Feng JQ
Mol Med Rep; 2013 Aug; 8(2):603-8. PubMed ID: 23807148
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells.
Liu CJ; Cheng YC; Lee KW; Hsu HH; Chu CH; Tsai FJ; Tsai CH; Chu CY; Liu JY; Kuo WW; Huang CY
Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms regarding potassium bromate‑induced cardiac hypertrophy without apoptosis in H9c2 cells.
Kuo SC; Li Y; Cheng YZ; Lee WJ; Cheng JT; Cheng KC
Mol Med Rep; 2018 Nov; 18(5):4700-4708. PubMed ID: 30221729
[TBL] [Abstract][Full Text] [Related]
12. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling.
Ye M; Zhang L; Yan Y; Lin H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369
[TBL] [Abstract][Full Text] [Related]
13. Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes.
Konorev EA; Vanamala S; Kalyanaraman B
Free Radic Biol Med; 2008 Dec; 45(12):1723-8. PubMed ID: 18926904
[TBL] [Abstract][Full Text] [Related]
14. Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts.
Choi HJ; Seon MR; Lim SS; Kim JS; Chun HS; Park JH
Exp Biol Med (Maywood); 2008 Dec; 233(12):1554-60. PubMed ID: 18849542
[TBL] [Abstract][Full Text] [Related]
15. MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway.
Cheng D; Tu W; Chen L; Wang H; Wang Q; Liu H; Zhu N; Fang W; Yu Q
Aging (Albany NY); 2021 Sep; 13(18):22556-22570. PubMed ID: 34587120
[TBL] [Abstract][Full Text] [Related]
16. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-induces NFAT/Fas/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways.
Shati AA
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):660-676. PubMed ID: 31811646
[TBL] [Abstract][Full Text] [Related]
18. CO and bilirubin inhibit doxorubicin-induced cardiac cell death.
Kim DS; Chae SW; Kim HR; Chae HJ
Immunopharmacol Immunotoxicol; 2009; 31(1):64-70. PubMed ID: 18756386
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/threonine kinase-dependent pathways.
Aihara Y; Kurabayashi M; Tanaka T; Takeda SI; Tomaru K; Sekiguchi KI; Ohyama Y; Nagai R
J Mol Cell Cardiol; 2000 Aug; 32(8):1401-14. PubMed ID: 10900167
[TBL] [Abstract][Full Text] [Related]
20. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
